Eindhoven University of Technology
Groene Loper 3, Eindhoven, Noord-Brabant, 5612 AE, The Netherlands
Overview
The vast majority of education is undergraduate education provided by the departments to students, who are adults with no other academic qualifications than a secondary education diploma. Some education is also provided to members of the postgraduate designer programs, but they are employed by the university and do not count as part of the student body. Undergraduate education was given in four- or five-year programs until 2002. Starting in 2002, following the entry into force of the Bologna Accords, the university switched to the bachelor/master structure. The undergraduate programs are now split into two programs each, a three-year bachelor program and a two-year master program. These programs are completely independent, in the sense that a bachelor can leave the university with his title and go to work, can enter a master's program at another university or continue on to the master's program of his department at the university. And bachelors from other universities can also enroll in the new master's programs.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 8
Sector focus
- Education
- Higher Education
- Universities
Investment portfolio
- Microsure
Participated · Series B · Oct 2023
Microsure develops robot-assisted systems for microsurgery, notably the MUSA-3 which is designed in close cooperation with microsurgeons and engineers. The company says MUSA-3 provides precision for microsurgeons and enables interventions that are virtually impossible to perform by hand. Microsure intends to use the new funding to finalize MUSA-3 development for clinical studies, followed by FDA clearance in the USA and CE-marking in Europe. The company is led by CEO Sjaak Deckers and was founded in 2016 by Eindhoven University of Technology and Maastricht University Medical Center. Microsure is based in Eindhoven, The Netherlands, and currently employs over 30 technical professionals. The recent financing strengthens its position to complete clinical validation and regulatory approvals. Microsure develops robot-assisted systems for microsurgery; its leading product MUSA is the first CE-marked and clinically available surgical robot assistant for open microsurgery. MUSA scales down motion and filters tremor to provide steadier manipulation, targeting procedures such as lymphatic-venous anastomosis, distal nerve repair and vascularized tissue transplantation. The company closed a €2.7 million Series B extension to continue the initial clinical roll-out and to further develop improvements to the system. The planned broader market availability of the improved MUSA system is expected in the course of 2022 after Covid-19 related delays. Microsure was founded in 2016 and is based in Eindhoven; it works with clinical and technical advisors including Maastricht University Medical Center+ as a leading clinical partner.